An in vitro and in vivo investigation into the suitability of compression coated tablets of indomethacin for the treatment of rheumatoid arthritis which follow circadian rhythms

References

• Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. (2001). In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release, 73:103–110.
   PubMed Web of Science ®Google Scholar
• Brayden DJ. (2003). Controlled release technologies for drug delivery. Drug Discov Today, 8:976–978.
   PubMedGoogle Scholar
• Paolisso G, Scheen AJ, Giugliano D, Sgambato S, Albert A, Varricchio M et al. (1991). Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab, 72:607–615.
   PubMed Web of Science ®Google Scholar
• White WB, Black HR, Weber MA, Elliott WJ, Bryzinski B, Fakouhi TD. (1998). Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol, 81:424–431.
   PubMed Web of Science ®Google Scholar
• Sunil SA, Srikanth MV, Sreenivasa Rao N, Uhumwangho MU, Latha K, Ramana Murthy KV. (2011). Chronotherapeutic drug delivery systems - an approach to circadian rhythms diseases. Curr Drug Deliv, 8:622–633.
   PubMed Web of Science ®Google Scholar
• Sangalli ME, Maroni A, Busetti C, Zema L, Giordano F, Gazzaniga A. (1999). In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology). Boll Chim Farm, 138:68–73.
   PubMedGoogle Scholar
• Leslie S. (1986). The Contin delivery system: dosing considerations. J Allergy Clin Immunol, 78:768–773.
   PubMed Web of Science ®Google Scholar
• Washington N, Wilson CG. (2006). Can oral controlled drug delivery meet the challenges posed by chronotherapeutics? Drug Deliv Technol, 6:1–5.
   Google Scholar
• Descombes S, Bonnet AM, Gasser UE, Thalamas C, Dingemanse J, Arnulf I et al. (2001). Dual-release formulation, a novel principle in L-dopa treatment of Parkinson’s disease. Neurology, 56:1239–1242.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Cui JH, Kim TW, Heo MY, Kim CK. (1998). Biphasic release characteristics of dual drug-loaded alginate beads. Arch Pharm Res, 21:645–650.
   PubMed Web of Science ®Google Scholar
• Smith RB, Kroboth PD, Folan MM, Kroboth FJ, Rosanske TW. (1993). Design and pharmacodynamic evaluation of novel dual release formulations of triazolam. Int J Clin Pharmacol Ther Toxicol, 31:422–429.
   PubMedGoogle Scholar
• Otsuka M, Matsuda Y. (1994). Controlled drug release of highly water-soluble pentoxifylline from time-limit disintegration-type wax matrix tablets. Pharm Res, 11:351–354.
   PubMed Web of Science ®Google Scholar
• Pozzi F, Furlani P, Gazzaniga A. (1994). The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J Contr Rel, 31:99–108.
   Web of Science ®Google Scholar
• Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. (1998). Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm, 71:137–146.
   Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana S, Prasad YV. (1999). Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery. Drug Dev Ind Pharm, 25:651–657.
   PubMed Web of Science ®Google Scholar
• Fernandez-Hervas MJ, Fell JT. (1998). Pectin:chitosan mixtures as coatings for colon-specific drug delivery: an in vitro evaluation. Int J Pharm, 169:115–119.
   Web of Science ®Google Scholar
• Ahrabi SF, Madsen G, Dyrstad K, Sande SA, Graffner C. (2000). Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur J Pharm Sci, 10:43–52.
   PubMed Web of Science ®Google Scholar
• Turkoglu M, Takka S, Baran H, Sakr A. (1999). Pectin hydroxyl propyl methyl cellulose drug delivery system for colon targeting. Pharm Pharmacol, 51:154.
   Google Scholar
• Turkoglu M, Ugurlu T. (2002). In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm, 53:65–73.
   PubMed Web of Science ®Google Scholar
• Ugurlu T, Turkoglu M, Gurer US, Akarsu BG. (2007). Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture. Eur J Pharm Biopharm, 67:202–210.
   PubMed Web of Science ®Google Scholar
• SCOTT JT. (1960). Morning stiffness in rheumatoid arthritis. Ann Rheum Dis, 19:361–368.
   PubMed Web of Science ®Google Scholar
• Kowanko IC, Pownall R, Knapp MS, Swannell AJ, Mahoney PG. (1981). Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol, 11:477–484.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A. (2007). Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharm, 57:99–109.
   PubMedGoogle Scholar
• Sawada T, Kondo H, Nakashima H, Sako K, Hayashi M. (2004). Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int J Pharm, 280:103–111.
   PubMed Web of Science ®Google Scholar
• IP2010. Uniformity of weight of single-dose preparations and Uniformity of content of single-dose preparations. The Indian Pharmacopoeia Commission, Ghaziabad, India. 2010;187–192.
   Google Scholar
• Zelkó R, Orbán A, Süvegh K. (2006). Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy. J Pharm Biomed Anal, 40:249–254.
   PubMed Web of Science ®Google Scholar
• Shigeoka T, Izawa O, Kitazawa K, Yamauchi F, Murata T. (1984). Studies on the metabolic fate of sucrose esters in rats. Food Chem Toxicol, 22:409–414.
   PubMed Web of Science ®Google Scholar
• Husband FA, Samey DB, Barnard MJ, Wilde PJ. (1998). Comparison of foaming and interfacial properties of pure sucrose monolaurates, dilaurate and commercial preparations. Food Hydrocolloid,12:237–244.
   Web of Science ®Google Scholar
• Tual A, Bourles E, Barey P, Houdoux A, Desprairies M, Courthaudon JL. (2006). Effect of surfactant sucrose ester on physical properties of dairy whipped emulsions in relation to those of O/W interfacial layers. J Colloid Interface Sci, 295:495–503.
   PubMed Web of Science ®Google Scholar
• ICH. Harmonised tripartite guideline: Stability testing of new drug substances and products ICH Q1A(R2). ICH Expert Working Group, Europe, Japan and USA. February 2003.
   Google Scholar